Neovasc Announces First Patient Enrollment In COSIMA Trial
VANCOUVER and MINNEAPOLIS – (NewMediaWire) – May 10, 2021 – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled in the COronarySInus Reducer for…